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Abstract
NF-κB essential modulator, NEMO, plays a key role in canonical NF-κB signaling induced
by a variety of stimuli, including cytokines and genotoxic agents. To dissect the different bio-
chemical and functional roles of NEMO in NF-κB signaling, various mutant forms of NEMO
have been previously analyzed. However, transient or stable overexpression of wild-type
NEMO can significantly inhibit NF-κB activation, thereby confounding the analysis of NEMO
mutant phenotypes. What levels of NEMO overexpression lead to such an artifact and what
levels are tolerated with no significant impact on NEMO function in NF-κB activation are cur-
rently unknown. Here we purified full-length recombinant human NEMO protein and used it
as a standard to quantify the average number of NEMOmolecules per cell in a 1.3E2
NEMO-deficient murine pre-B cell clone stably reconstituted with full-length human NEMO
(C5). We determined that the C5 cell clone has an average of 4 x 105 molecules of NEMO
per cell. Stable reconstitution of 1.3E2 cells with different numbers of NEMOmolecules per
cell has demonstrated that a 10-fold range of NEMO expression (0.6–6x105 molecules per
cell) yields statistically equivalent NF-κB activation in response to the DNA damaging agent
etoposide. Using the C5 cell line, we also quantified the number of NEMOmolecules per
cell in several commonly employed human cell lines. These results establish baseline num-
bers of endogenous NEMO per cell and highlight surprisingly normal functionality of NEMO
in the DNA damage pathway over a wide range of expression levels that can provide a
guideline for future NEMO reconstitution studies.
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Introduction
The Nuclear Factor kappa B (NF-κB) family of dimeric transcription factors regulates gene ex-
pression involved in multiple biological processes including immune and inflammatory re-
sponses and control of cell proliferation and death [1]. In the absence of stimuli, a NF-κB
dimer is kept inactive in the cytoplasm of most cells via association with a member of the inhib-
itor of NF-κB (IκB) family, which includes IκBα. An important regulator of canonical NF-κB
signaling is the IκB kinase (IKK) complex which consists of two catalytic subunits, IKKα and
IKKβ, and a regulatory subunit, NEMO (NF-κB essential modulator, IKKγ) [2,3]. Once activat-
ed by incoming signals, the IKK complex phosphorylates IκB to stimulate polyubiquitination
and proteasome-mediated degradation to release NF-κB [4]. The liberated NF-κB translocates
to the nucleus and regulates its target gene expression.
Because the IKK complex represents the convergence point in activating canonical NF-κB
signaling, a considerable amount of research has been conducted to understand the mechanism
of activation and regulation of the IKK complex. In particular, the role of the non-catalytic sub-
unit NEMO in IKK complex regulation has been studied intensively (reviewed in [2]). These
studies have highlighted the role of NEMO as a ubiquitin binding protein to promote IKK acti-
vation [5–7]. The recruitment of NEMO to polyubiquitin scaffolds assembled by the upstream
signaling events permits the recruitment of the catalytic IKK subunits to the upstream kinase,
TAK1 (TGFβ activated kinase 1), which is also recruited to the ubiquitin scaffolds via its ubi-
quitin binding subunits, TAB2/3, to be phosphorylated and activated [8–10].
In addition to its well accepted role as an IKK regulatory subunit, NEMO also performs an
additional upstream role to permit communication between the nuclear DNA damage activat-
ed kinase ATM (ataxia telangiectasia mutated) and the cytoplasmic IKK complex to induce
NF-κB signaling in response to genotoxic agents (reviewed in [11]). To investigate the
distinct functions of NEMO, a variety of mutant forms of NEMO have been previously ana-
lyzed [12–15]. However, since overexpression of NEMO can result in inhibition of NF-κB sig-
naling [16–18], it is important to control the amount of NEMO expressed in different cell
systems in order to define the various functions of NEMO without being confounded by arti-
facts associated with high NEMO expression levels. Even so, it is generally undefined what the
physiological levels of NEMO are, i.e., how many NEMOmolecules are expressed in different
cell systems, and what the impact of different expression levels of NEMO is on NF-κB activa-
tion by different stimuli, including genotoxic agents.
To answer these questions, purified recombinant full-length NEMO is needed to provide
standards for quantification of cellular NEMO levels. Since purification of soluble, recombi-
nant full-length NEMO from E. coli in high concentrations is technically challenging [19], we
first optimized a NEMO purification protocol from E. coli. We then quantified the average
number of NEMOmolecules per cell using 1.3E2 NEMO-deficient murine pre-B cell clone sta-
bly reconstituted with full-length human NEMO (C5) previously characterized by our lab
[12,13]. Next, we generated 1.3E2 clones stably expressing different amounts of NEMO to de-
termine the impact of known numbers of NEMO per cell on NF-κB activation by the DNA
damaging agent etoposide, which creates DNA double strand breaks via inhibition of topo-
isomerase II. Our study demonstrates that a 10-fold range of NEMO levels has surprisingly lit-
tle impact on NF-κB activation by etoposide and suggests that mutant NEMO phenotypes can
be analyzed accurately as long as the level of NEMO remains within this range. We also used
the C5 cell line to determine the average number of NEMOmolecules per cell in several
human cell lines often employed in NF-κB signaling studies to highlight the utility of the C5
cell line as a standard to determine the cellular content of NEMO proteins in different
cell systems.
Effect of Varying NEMO Amounts on NF-κB Activation
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Materials and Methods
Reagents
The following antibodies were used: antibody against NEMO (FL-419, sc-8330, Santa Cruz
Biotechnology), Flag-HRP (A8592, Sigma), Tubulin (CP06, EMDMillipore), Actin (sc-1616,
Santa Cruz Biotechnology), and IKKα/β (sc-7607, Santa Cruz Biotechnology). Anti-rabbit and
anti-mouse antibodies conjugated to horseradish peroxidase were obtained from GE Health-
care. Etoposide (E1383, Sigma) and bacterial LPS (L2880, Sigma) were purchased from Sigma-
Aldrich. Glutathione-agarose beads and Halt Protease Inhibitor Cocktail was obtained from
Thermo Scientific.
Purification of recombinant full-length human NEMO protein
To purify recombinant full-length human NEMO, NEMO/pGEX6p-1 plasmid was trans-
formed into Rosetta2 BL21 cells and a transformant was grown in 20 ml of LB medium supple-
mented with 100 μg/ml ampicillin and 34 μg/ml chloramphenicol at 37°C for overnight. The
overnight seed culture was diluted in 2 L of LB medium containing 100 μg/ml ampicillin and
34 μg/ml chloramphenicol and grown at 37°C until the absorbance at 600 nm reached 0.6–0.7.
The bacterial culture was kept at 4°C for 30 minutes while the temperature of the shaker was
cooled down to 28°C. 0.5 mM isopropyl β-D-thiogalactoside (IPTG) was then added to the cul-
ture, and the culture was incubated at 28°C for 3 hours to induce the protein. After harvesting
the cells by centrifugation at 4000 rpm for 20 minutes at 4°C, the bacterial pellet was washed
with 1X PBS and stored at −20°C for later purification or resuspended in 30 ml of lysis buffer
(20 mMHEPES-KOH/7.6, 300 mM potassium acetate, 20% glycerol, 10 mMmagnesium chlo-
ride, freshly added 1X Halt Protease inhibitor cocktail, freshly added 5 mM β-mercaptoetha-
nol) per 1 L bacterial culture along with 125 μg/ml lysozyme. The culture was then incubated
for 20 minutes on ice. The lysate was sonicated with 6 short burst of 20 sec followed by inter-
vals of 40 sec for cooling and centrifuged at 10000 rpm for 20 minutes at 4°C to remove cell de-
bris. The lysate was centrifuged again at 23000 rpm for 60 minutes at 4°C to remove the any
leftover cell debris. The lysate was diluted up to 150 ml of lysis buffer.
To equilibrate glutathione agarose beads (Thermo Pierce), 1 ml of the beads (wet bed vol-
ume) were washed with lysis buffer twice and carefully poured into a closed column. The beads
were then allowed to settle without flow. Once the beads were gravity packed, 100 ml of lysis
buffer was run through by gravity flow. The diluted lysate prepared above was loaded onto the
equilibrated column and ran at a rate of 30 ml/hr at 4°C. The flow-through was reloaded onto
the column and the binding step was repeated twice with a 50 ml/hr flow rate at 4°C. The beads
were washed with 150 ml of lysis buffer with 30 ml/hr flow rate at 4°C.
For elution of GST-NEMO, 300 μl of freshly prepared elution buffer (10 mM reduced gluta-
thione, 50 mM Tris-HCl/8.0, freshly added 1X Halt Protease inhibitor cocktail, freshly added
5mM β-mercaptoethanol) was applied using gravity flow and collected in a 1.5 ml microcentri-
fuge tube. For cleavage of GST by GST- human rhinovirus 3C protease, the beads containing
GST-NEMO were resuspended in 9 ml of lysis buffer, transferred to a new 14 ml conical tube,
and washed with 10 ml of lysis buffer twice. 100 μl aliquot of the beads (wet bed volume) was
transferred to an Eppendorf tube and twice washed with dialysis buffer (50 mMHEPES-KOH/
7.6, 100 mM potassium acetate, 20% glycerol, freshly added 5 mM β-mercaptoethanol). 400 μl
of dialysis buffer containing 4 μg of GST- human rhinovirus 3C protease was added to the wet
beads and the beads were rotated at 4°C overnight. The beads were then centrifuged at 1500 rpm
for 20 sec at 4°C to remove GST- human rhinovirus 3C protease and to recover the GST
cleaved NEMO protein in the supernatant. To determine the concentration of the purified
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recombinant NEMO, proteins were analyzed on SDS-PAGE gel together with a serial dilution
of BSA at known concentrations. The concentration of GST cleaved NEMO protein was con-
firmed by absorbance at 280 nm using Nanodrop (Thermo Fisher Scientific Inc.) using the ex-
tinction coefficient of 14440 M−1 cm−1 which was calculated from the NEMO sequence.
Preparation of GST- human rhinovirus 3C protease
GST- human rhinovirus 3C protease production was induced in BL21 strain E. coli with
0.5 mM IPTG for 4 hours at 25°C. Cells were collected by centrifugation, resuspended in lysis
buffer (1X PBS, 250 mMNaCl, 0.1% Tween-20, 10 mM β-mercaptoethanol, 1 mM PMSF,
1 mM benzamidine), and lysed by sonication with 1 mg/ml lysozyme. Lysate was clarified by
centrifugation for 1 hour at 45,000xg and incubated with glutathione agarose beads at 4°C for
1 hour. The beads were washed extensively with lysis buffer. Proteins were eluted with reduced
glutathione added to the wash buffer, dialyzed into cleavage buffer (50 mM Tris-Cl pH 8.0,
75 mM KCl, 50% glycerol), and maintained at −20°C.
Validation of purified recombinant NEMO by MS/MS analysis
A 48 kD protein band from Coomassie blue stained sodium dodecyl sulfate (SDS)-PAGE gel
was sliced out, cut into smaller pieces into an Eppendorf tube, and destained by washing three
times for 10 min in 200 μl of 50% (v/v) acetonitrile solution containing 50 mMNH4HCO3.
The gel pieces were then reduced by 50 μl of 20 mM dithiothreitol, 100 mMNH4HCO3 for 30
minutes at 55°C, alkylated in 50 μl of 20 mM iodoacetamide solution, washed with 100% aceto-
nitrile, and dried at room temperature. 10 μl of modified trypsin (Promega, sequencing grade)
(100 μg/ml) in 100 mMNH4HCO3 was added on the dried gel pieces in the Eppendorf tube
and incubated at 37°C overnight. The tryptic peptides were injected onto the C18 column (Wa-
ters, 100um x 10cm) and eluted with a linear gradient for 60 minutes from 1 to 45% acetonitrile
(in water with 0.1% FA) at a flow rate of 500 nl/min. The effluent was electro-sprayed into the
LTQ (Thermo Scientific) mass spectrometer. Database search was carried out using both
Sequest and X! Tandem algorithms, and identification confidence was calculated by a pub-
lished method [20]. Human protein sequence database (Uniprot) was used.
In vitro translation and GST-pull down and co-immunoprecipitation
assay
Flag-IKKβ/pcDNA3.1(+) was in vitro translated with TNT Coupled Reticulocyte Lysate Sys-
tems (Promega) as described by the manufacturer using 1 μg of the plasmid and 50 μl final re-
action volume. 1/50 of the reaction was separated by 10% SDS-PAGE and verified by
immunoblotting with Flag antibody. For GST pull-down assay, 1 μg of GST or GST-NEMO
protein was incubated with 1/5 of the translation reaction containing mock or IKKβ in 800 μl
of IP buffer (50 mM Tris-HCl, pH7.5, 150 mMNaCl, 1 mM EDTA, 0.25% Triton X-100,
1 mM DTT, 1X Halt Protease inhibitor cocktail). The mixture was rotated for 5 hours at 4°C.
20 μl of glutathione beads was added to the mixture, and the binding mixture was rotated for
another 2 hours at 4°C. After washing the glutathione beads 4 times with wash buffer (50 mM
Tris-HCl, pH7.5, 300 mMNaCl, 1 mM EDTA, 0.5% Triton X-100, 1 mMDTT, 1X Halt Prote-
ase inhibitor cocktail), the GST-NEMO bound IKKβ was analyzed by 10% SDS-PAGE and
immunoblotted with Flag antibody. For co-immunoprecipitation analysis, 1 μg of GST or
GST-cleaved NEMO protein was incubated with 1/5 of the translation reaction containing
mock or IKKβ in 800 μl of the IP buffer containing 2 μg of anti-NEMO antibody. The mixture
was then rotated for 5 hours at 4°C and then 20 μl of protein G-sepharose was added to the
mixture. The binding mixture was rotated for another 2 hours at 4°C. After 4 times of washing
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the beads with the wash buffer, the immunoprecipitated proteins were analyzed by immuno-
blotting as above.
Cell culture
1.3E2 murine pre-B cells (obtained from Israel’s group [21]) stably expressing 6x Myc-tagged
human NEMO (C5) and 70Z/3 cells (TIB-158, ATCC) were cultured in RPMI1640 medium
(GE healthcare HyClone) supplemented with 10% (v/v) fetal bovine serum (GE healthcare
HyClone), 50 μM β-mercaptoethanol, and antibiotics (100 IU/ml penicillin and 100 μg/
mlstreptomycin) as described previously [22]. Human Jurkat T cells (TIB-152, ATCC) were
cultured in RPMI1640 medium supplemented with 10% fetal bovine serum and antibiotics as
above. Human retinal pigment epithelial (RPE) cells (obtained from Burkard’s group [23])
were cultured in DMEM/F12 medium (GE healthcare HyClone) supplemented with 10% fetal
bovine serum and antibiotics as above. Human embryonic kidney (HEK293) cells (CRL-1573,
ATCC) and HeLa cells (CCL-2, ATCC) were cultured in DMEMmedium (Corning Cellgro)
supplemented with 10% fetal bovine serum and antibiotics as described above. All cells were
grown at 37°C in 5% CO2 humidified incubator (Thermo Scientific) except HEK293 cells,
which were grown at 37°C in a 10% CO2 humidified incubator on 0.1% (w/v) gelatin-coated
dishes. All cells were passaged at least twice weekly before reaching a cell density of 1 x 106 per
ml for suspension cells or reaching 90% confluence for adherent cells. Immunofluorescence
analysis was done as in [12,13] except for anti-NEMO antibody (FL-419) used for detection of
NEMO.
Generation of NEMO reconstituted 1.3E2 cell clones
1.3E2 cells were reconstituted with wild-type human NEMO as described previously [22].
Briefly, 5 x 106 1.3E2 cells were electroporated with 40 μg of human NEMO/pcDNA3.1(+), im-
mediately split into three 10 cm dishes to ensure isolation of independent clones, and incubated
for 24 hours in growth media. G418 (Mediatech) at 1 mg/ml concentration was then added to
select for resistant pools over 4–5 days. Dead cells were removed by using lymphocyte separa-
tion medium (Mediatech). The G418-selected clones were isolated (*40 clones from each of
the three pools) and individually placed in each well of a 96-well plate with 0.2 mg/ml G418 for
*2 weeks before expanding each clone (*12–20 clones for each pool) for the analysis of
NEMO expression by Western blotting with NEMO antibody, using the C5 clone as the stan-
dard in each gel. Generally, 2–4 clones from each pool had equivalent NEMO expression as C5.
Protein extraction was done by 2x SDS Laemmli sample buffer or using Totex buffer (20 mM
HEPES, pH7.9, 350 mMNaCl, 1 mMMgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 20% glycerol, 1%
NP-40, 0.5 mM DTT, 1X Halt Protease inhibitor cocktail).
Quantification of cellular NEMO numbers
107 C5 cells were pelleted at 2000 rpm for 2 minutes and resuspended with 10 ml of 1X PBS re-
sulting in a concentration of 106 C5 cells/ml. The resuspended cells were aliquoted to make a
series of diluted cells: 1 x 104, 2.5 x 104, 5 x 104, 1 x 105, 2.5 x 105, 5 x 105 and 1 x 106 C5 cells.
Purified recombinant NEMO protein (GST cleaved) was also diluted with 1X PBS to make 0.1,
0.5, 1, 5, 10, 50, 100 ng diluted protein series. 2x SDS Laemmli sample buffer was added to the
diluted cells or recombinant NEMO protein. The samples were boiled for 5 minutes and sepa-
rated on 10% SDS-PAGE gels. The separated proteins were transferred onto polyvinylidene
difluoride (PVDF) membranes and visualized by Western blotting with anti-NEMO antibody.
To calculate the number of NEMOmolecules per cell on average, the intensity of visualized
NEMO bands were measured by densitometry analysis. The intensity of bands at the linear
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range, corresponding for 1, 5, and 10 ng of the purified recombinant NEMO protein and
5 x 104, 1 x 105, 2.5 x 105 C5 cells, were normalized to the intensity of band corresponding to
1 ng of the purified recombinant NEMO protein. A graph and equation were achieved from
the normalized intensity to estimate the number of NEMOmolecules per cell on average.
Based on this equation, the intensity for 1 x 105 C5 cells was equivalent to the intensity of
band corresponding to 4.55 ng of the purified recombinant NEMO protein. Using molecular
weight of 6x myc tag-human NEMO (62.6 kDa), 4.55ng equals to 72.7 fmoles or approximately
4 X1010 NEMOmolecules, indicating approximately 4 x 105 molecules of human NEMO pro-
tein is expressed in a single C5 cell on average. Three independent analyses were performed by
three investigators on different days with the same outcomes obtained (with R2 value ranging
from 0.92 to 0.99).
To quantify the number of NEMOmolecules in different human cell lines, 3 x 106 cells each
of Jurkat, HEK293, HeLa, or RPE, and C5 were pelleted at 13,000 x g for 10 s in a table-top
microcentrifuge at room temperature, rinsed once with phosphate-buffered saline (PBS), resus-
pended in 50 μL PBS, and lysed by the addition of 250 μL 2x SDS Laemmli sample buffer. Sam-
ples were then immediately boiled for 10 minutes, loaded by cell number in a titration from
106 to 104 cells, and separated on 10% SDS-PAGE gels. The separated proteins were visualized
by Western blotting with anti-NEMO antibody as described above. Densitometry analysis
using ImageJ software was used to measure the intensity of the visualized NEMO bands for
each blot, and the signals were then normalized to either 2.5 x 105 or 5 x 105 of corresponding
C5 cells for each blot. Using the normalized intensities, a linear graph and equation were gener-
ated for each cell type with R2 value> 0.94. The average number of NEMOmolecules per cell
was then determined by calculating the ratio of the slopes between each cell type Jurkat,
HEK293, HeLa, or RPE, and C5 and multiplying this ratio by the estimated average number of
NEMOmolecules per C5 cell.
Statistical analysis
Values are presented as means ± S.E.M. with the indicated number of independent experi-
ments. The statistical significance of differences between groups was determined by the Stu-
dent's t test. P values less than 0.05 were considered statistically significant.
Results
Purification of full-length NEMO
To purify sufficient amounts of full-length recombinant human NEMO protein, a human
NEMO construct was transformed into Rosetta2 BL21 cells and the NEMO protein was in-
duced. Regardless of different induction temperatures (19–30°C), at least 60% of the induced
NEMO protein was found in the insoluble fraction (Fig. 1A, lane 6). To reduce the aggregation
of the NEMO protein and maximize the yield of NEMO protein in the soluble fraction, the bac-
terial lysate was diluted with a large volume of lysis buffer (150 ml per 1 L of the bacterial cul-
ture). The diluted lysate was slowly loaded onto a glutathione column with three repeated
applications to further reduce the potential of NEMO aggregation. In addition, β-mercap-
toethanol freshly added to all buffers increased the yield of the soluble NEMO protein, possibly
by further preventing protein aggregation [19].
Despite extensive washing with lysis buffer, the GST-NEMO fraction, which was eluted
with elution buffer containing 10 mM reduced glutathione, contained nonspecifically bound
bacterial proteins (Fig. 1A, lane 4). However, direct cleavage of GST-NEMO from GSH-beads
with GST-tagged human rhinovirus 3C protease resulted in the recovery of cleaved NEMO
protein fractions that contained significantly reduced protein contaminants compared to the
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GST tagged NEMO fraction (Fig. 1B, lane 5 and 6). Even so, the NEMO protein was extremely
susceptible to aggregation after the GST tag was removed. Thus, it was important to maintain
at least two bead volumes of cleavage buffer to prevent NEMO protein aggregation. Approxi-
mately 0.3 mg/ml of GST-cleaved full length NEMO and 1 mg/ml of GST-NEMO in a soluble
state could be obtained.
Fig 1. Purification of full length recombinant human NEMO protein. (A) SDS–PAGE gel stained with Coomassie Brilliant Blue R-250 for the protein
purification profile. (B) 10 μl of purified recombinant NEMO proteins were loaded with a serial dilution of BSA at known concentrations (C) GST or GST-
NEMO protein was incubated with in vitro translated mock or IKKβ for GST pull-down assay (lane 1–4), or GST or GST-cleaved NEMO protein was incubated
with in vitro translated mock or flag-IKKβ for co-immunoprecipitation with anti-NEMO antibody (lane 7–10). Flag-IKKβ in the complexes or inputs (lanes 5 and
6) were separated on SDS-PAGE gel and immunoblotted with flag antibodies.
doi:10.1371/journal.pone.0116374.g001
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The nature of the purified NEMO protein was confirmed by excising*48 kD protein band
from Coomassie blue-stained SDS-PAGE gel followed by MS/MS analysis. Sequence coverage
with high confident peptides was 55.8% (S1 Fig.). Moreover, both purified GST-NEMO and
GST-cleaved NEMO bound to in vitro translated flag-IKKβ by GST-pull down assay and co-
immunoprecipitation assay, respectively (Fig. 1C). These results confirmed the purity and
identity of the purified recombinant NEMO protein, which was used for subsequent cellular
NEMO quantification studies.
Determination of the average number of NEMOmolecules in the C5
clone
To estimate the average number of NEMOmolecules present within a cell, we employed a
1.3E2 clone (C5) which stably expresses 6x Myc-tagged NEMO at approximately the same lev-
els as endogenous NEMO levels detected in 70Z3 cells, the parental cell line of 1.3E2, using
FL419 NEMO antibody. C5 and 70Z/3 cells display similar levels of NF-κB activation in re-
sponse to etoposide (VP16) and lipopolysaccharides (LPS; membrane signaling control) [13].
Different amounts of purified recombinant NEMO protein along with cell extracts represent-
ing different C5 cell numbers were analyzed by Western blotting using anti-NEMO antibody
(Fig. 2A and S2 Fig.). Based on quantification of the intensity of the NEMO bands through
densitometric analysis, approximately 4 x 105 molecules of human NEMO protein is expressed
in a single C5 cell on average (Fig. 2B).
Generation of 1.3E2 clones expressing different amounts of NEMO
protein
To determine the impact of different NEMO expression levels on NF-κB activation by geno-
toxic agents, we stably reconstituted NEMO in 1.3E2 cells with tag-less human NEMO as de-
picted in Fig. 3A. An example of the Western blot analysis of 1.3E2 cell clones stably expressing
different amounts of NEMO is shown in Fig. 3B. Based on the expression of NEMO relative to
the C5 clone, multiple independent stable clones were further expanded in order to determine
the average number of NEMO expression per cell and their respective NF-κB activation poten-
tials in response to etoposide treatment. When different clones were analyzed by immunofluo-
rescence analysis using anti-NEMO antibody, the expression of NEMO detected in individual
cells was relatively uniform (Fig. 3C).
We next treated multiple 1.3E2 clones, stably expressing different levels of NEMO, with eto-
poside for 1 hour and analyzed NF-κB activation by EMSA. Since NEMO is prone to precipitate
in vitro [19], the amount of NEMO in the clones was measured using two different extraction
methods: 2x SDS Laemmli sample buffer and Totex buffer, the latter of which was used to pre-
pare cell extracts for EMSA assay as NF-κB proteins are efficiently extracted in the native state.
Amounts of extracted NEMO were similar in both methods for tag-less NEMO (Fig. 4A).
To estimate the number of NEMOmolecules in the NEMO reconstituted clones shown in
Fig. 4A, the equation derived in Fig. 2B and a comparison of the NEMO bands between the
clones and C5 were used. Based on our calculations, we estimated that clones 6E, 6B, 5D, 5E
and 4C express 0.6, 2.7, 2.7, 6 and 7 x 105 molecules of NEMO per cell. All of these NEMO
clones showed almost no detectable basal NF-κB activity (Fig. 4B). In response to etoposide
treatment, a trend of increasing NF-κB activation was observed as the amount of NEMO in-
creased (peaking with clone 6B), which became modestly reduced in clones which expressed
even higher amounts of NEMO (Fig. 4B). In contrast, the NF-κB activation in response to LPS
was not affected by the amount of NEMO in this range (Fig. 4C). More careful analysis using
both a time course (Fig. 5A) and dose response (Fig. 5B) showed similar trends with clone 6B
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showing the highest NF-κB activation and lower or higher amounts of NEMO than clone 6B
showing reduced NF-κB activation. However, quantification of EMSA data from multiple bio-
logical replicates did not show statistically significant impacts (Fig. 5A and 5B, lower graphs).
Thus, NF-κB activation by etoposide is surprisingly invariant across a 10-fold range of NEMO
expression in the 1.3E2 cell system.
Determination of the average number of NEMOmolecules per cell in
multiple human cell lines
Various human cell lines are often employed to study NF-κB signaling by different stimuli, in-
cluding genotoxic agents; however, the number of NEMOmolecules expressed per cell in any
Fig 2. Determination of the average number of NEMOmolecules in the C5 clone. (A) Protein extracts from the indicated number of C5 cells and
indicated amount of purified recombinant human NEMO proteins were separated on SDS-PAGE gel and immunoblotted with NEMO antibody. (B) Graph
representing the intensity of the bands corresponding to NEMO in three independent replicates as shown in (A) and an equation derived from the graph. Error
bars represent S.E.M.
doi:10.1371/journal.pone.0116374.g002
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human cell line remains undefined. Using the C5 clone as a standard, we sought to estimate the
average number of NEMOmolecules in the following human cell lines: Jurkat T lymphocytic,
HEK293 embryonic kidney, HeLa cervical, and RPE retinal pigment epithelial cells. Cell ex-
tracts of each cell line, as well as those of the C5 clone, were prepared using 2x SDS Laemmli
buffer and analyzed by Western blotting using anti-NEMO antibody (Fig. 6). Quantification of
the NEMO band intensities yielded the following estimates for the average number of NEMO
molecules per cell for each cell line: Jurkat—1.3 x 106; HEK293–1.0 x 106; HeLa—1.0 x 106;
RPE—2.0 x 106 (Table 1). All of these human cell lines are considerably larger than 1.3E2 pre-
B cells, which may account for the relatively larger average numbers of NEMOmolecules
per cell.
Fig 3. Generation of 1.3E2 clones expressing different amounts of NEMO protein. (A) Work flowchart to generate NEMO reconstituted 1.3E2 cell
clones. (B) An example of Western blots with different NEMO stable clones. Protein extracts from different 1.3E2 clones were separated on SDS-PAGE gel
and immunoblotted with NEMO antibody. Tubulin was used as a loading control. (C) An example of immunofluorescence analysis with NEMO antibody
(Green) in a NEMO reconstituted 1.3E2 stable clone. Nuclei were visualized by Hoechst staining (Blue).
doi:10.1371/journal.pone.0116374.g003
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Fig 4. Effects of NEMO amount on NF-κB activation. (A) Cell extracts from equal numbers of 1.3E2 clones
expressing different amounts of NEMO protein were generated using either 2x SDS Laemmli sample buffer
or Totex buffer. The cell extracts were separated on SDS-PAGE gel and immunoblotted with NEMO, IKKα/β,
and actin antibodies. (B, C) The 1.3E2 clones as in A were left untreated or treated with etoposide (VP16,
5 μM, 1 hr) in B or LPS (10 μg/ml, 30 min) in C. P represents pool of the 1.3E2 clones before isolation of
individual clones. Protein extracts were examined by EMSA andWestern blotting using NEMO, IKKα/β, and
tubulin antibodies.
doi:10.1371/journal.pone.0116374.g004
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Fig 5. Effects of NEMO amount on NF-κB activation in response to etoposide. (A) Time course analysis.
The indicated 1.3E2 clones were left untreated or treated with 5 μMVP16 for indicated times and analyzed
by EMSA. Three independent experiments were performed as above on different days. The NF-kB bands
were quantified and fold inductions of NF-κB DNA binding activity were graphed below. Error bars represent
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Discussion
In previous studies, investigation of the functional significance of NEMO and its mutants in
multiple NF-κB signaling pathways utilized reconstitution of NEMOmutants in NEMO-defi-
cient 1.3E2 murine pre-B cells, R5 rat fibroblast, and Jurkat human T cells, or NEMO-null
mouse embryo fibroblasts [12,21,24,25]. The interpretation of the functional significance of
mutant NEMO proteins is confounded by the potential artifacts associated with their overex-
pression as overexpression of even the wild-type NEMO protein can significantly inhibit NF-
κB signaling [16–18]. Indeed, while NEMO was originally cloned through functional restora-
tion of NF-κB signaling by its stable reconstitution in NEMO-deficient R5 and 1.3E2 cells [21],
it was also independently cloned by another group as IKK/NF-κB inhibitor protein upon its
overexpression [26]. One approach to control the expression of NEMOmutants is to generate
inducible cell systems (e.g., doxycycline-inducible system) or use of knock-in technologies
(e.g., CRISPR) [27,28]. Alternatively, co-expression of a marker protein (e.g., CD2 or GFP) as a
NEMO fusion or expression from an internal ribosome entry sequence within a single expres-
sion plasmid may be used as a surrogate marker of expression quantified and isolated by FACS
sorting [18]. Even with these approaches, it may be necessary to ensure the expression level of
NEMO to be "physiological" by comparing the expression of mutant NEMO proteins to the en-
dogenous levels of the parental cell systems as comparison to wild-type NEMO protein may be
S.E.M. (B) Dose response analysis. The indicated 1.3E2 clones were left untreated or treated with the
indicated concentration of etoposide (VP16) for 1 hr. The quantification and graph were done as in A.
doi:10.1371/journal.pone.0116374.g005
Fig 6. Determination of the average number of NEMOmolecules in multiple human cell lines. Representative NEMOWestern blots of protein extracts
from the indicated number of Jurkat, HEK293, HeLa, and RPE cells compared to protein extracts from the indicated number of C5 cells are shown. *
represents non-specific band. Each blot was performed three biological replicates except for HEK293 which was two biological replicates.
doi:10.1371/journal.pone.0116374.g006
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insufficient to draw accurate conclusions if the wild-type NEMO expression levels are highly
overexpressed compared to the endogenous levels.
We have previously employed stable 1.3E2 cell clones to study NEMOmutant phenotypes
in NF-κB signaling induced by genotoxic agents [12,13,29]. The expression of NEMO in stable
1.3E2 clones remains generally stable over many passages and cryopreservation steps, and indi-
vidual cells within a given clonal population generally express similar levels as assessed by
immunofluorescence analysis (e.g., Fig. 3C). In contrast, expression of NEMO in individual
cells of a stable pool population is typically highly variable, making it a generally unsuitable sys-
tem to study NEMOmutant phenotypes as the NF-kB activation in those individual cells with
very low or high NEMO expression will likely show different phenotypes as those with more
physiological NEMO expression levels within a stable pool. However, it is technically challeng-
ing to match the expression levels of NEMO in stable clones across different mutant NEMO
versions. Our current study demonstrates that the levels of NEMO do not have to be precisely
matched to draw functionally relevant conclusions in the context of 1.3E2 reconstitution sys-
tem. Based on our quantification analysis, using the C5 stable clone that expresses approxi-
mately 4 x 105 molecules of human NEMO protein per cell as a standard, we found that a
range of 0.6–6 x 105 NEMOmolecules per cell (a 10-fold range) is functionally equivalent with
statistically insignificant impact on etoposide-induced NF-κB activation as measured by
EMSA analysis.
Since our previous studies suggested that only “IKK-free” NEMO, which is not bound to
IKKα/β, mediates nuclear signaling in response to genotoxic agents [12], we originally consid-
ered the possibility that the increased amounts of NEMO beyond some threshold level (per-
haps set by the levels of IKKα/β subunits) might increase the level of NF-κB activation in
response to genotoxic agents by increasing free NEMO. Indeed, there was a trend of modest in-
crease in NF-κB activation by etoposide as the level of NEMO increased from clone 6E to 6B/
5D (Fig. 4A and 4B). As the level of NEMO further increased, etoposide-induced NF-κB activa-
tion was modestly reduced and a greater decrease in NF-κB activation was found in some
clones that expressed an amount of NEMO beyond this range (data not shown). Despite the
varied NEMO levels from undetectable to that which is much higher than the C5 clone, the
amount of IKKα/β expression was invariant, suggesting that the levels of IKK catalytic subunits
are not regulated by NEMO protein in this cell type. Thus, estimation of the number of IKKα/β
molecules per 1.3E2 cell and the definition of the stoichiometry of NEMO and IKKα/βmole-
cules would be informative for further elucidation of the mechanisms involved in NF-κB acti-
vation by genotoxic agents. It is also possible that "IKK-free”NEMO is liberated from NEMO-
IKK complexes upon stimulation with genotoxic agents and therefore the basal stoichiometry
of NEMO and IKKα/βmolecules may be insufficiently informative. As such, additional studies
aiming at defining the dynamics of NEMO-IKKα/β complexes during cell stimulation may
also be critical to improve our understanding of NF-κB signaling by DNA damaging agents.
Table 1. Average number of NEMO molecules per cell of various cell lines compared to C5.
Cell Line Ratio to c5 Average # NEMO molecules/cell
Jurkat 3.1 ± 0.2 1.3 x 106
HEK293 2.5 ± 0.1 1.0 x 106
HeLa 2.5 ± 0.2 1.0 x 106
RPE 5.6 ± 0.1 2.0 x 106
Biological replicates were performed as such: Jurkat, HeLa, and RPE: n = 3, HEK293: n = 2.
doi:10.1371/journal.pone.0116374.t001
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The level of NEMO expression in the C5 clone was stable over multiple cryopreservation cy-
cles and over multiple independent analyses; therefore, it may be useful as a standard cell line
to estimate the number of NEMOmolecules in other human cell types as we have done so for
several commonly used human cell lines. However, we cannot rule out the possibility of some
posttranslational modifications of NEMO altering the degree of epitope recognition by anti-
NEMO antibody. The cell lines derived from non-human species may also need to be recali-
brated by the use of recombinant full-length NEMO protein standards generated from the spe-
cies of interest as different anti-NEMO antibodies likely recognize NEMO proteins from
different species with varying efficiencies depending on the conservation of the epitopes
being detected.
As part of the NEMO quantification studies, we generated recombinant full-length human
NEMO protein to be used as a molecular standard. Even though multiple groups have previ-
ously purified recombinant NEMO protein for biochemical study, the recombinant NEMO
proteins were generally purified as fusion proteins [19,30–32] and we were unable to find a
study that reports a purification protocol for untagged full-length recombinant wild-type
NEMO protein. Therefore, we sought to optimize a NEMO purification protocol to obtain rela-
tively pure and concentrated amounts of the soluble, full-length, and untagged NEMO protein.
A well-appreciated obstacle in the purification of recombinant full-length NEMO protein is
protein aggregation and precipitation. While the NEMO protein was more soluble as GST-fu-
sion protein, it became more susceptible to aggregation when the GST was removed from the
protein, suggesting GST-induced dimerization of NEMO potentially reduces NEMO aggrega-
tion at high concentrations. Agou et al. suggested the use of neutral detergents such as dodecyl
maltoside to prevent this aggregation, however this increased the co-purification of bacterial
DnaK protein with NEMO protein and thus decreased overall purity [30]. Whitty and col-
leagues have recently generated an N-terminal seven cysteines-to-alanines substitution mutant
of NEMO to increase the purification of soluble NEMO protein by preventing intermolecular
disulfide bond formation [19]. Another possible way to increase the solubility of NEMO pro-
tein is to co-purify NEMO with other proteins that interact with NEMO to prevent NEMO ag-
gregation, such as the IKK catalytic subunits [32]. We found that keeping the bacterial lysate
dilute in large volumes and adding a fresh reducing regent to all the buffers increased yield of
soluble NEMO protein. Moreover, direct cleavage of GST-NEMO proteins from the GSH-
beads by GST-tagged human rhinovirus 3C protease in large reaction volumes also resulted in
isolation of soluble NEMO with high purity and at a maximal concentration of 0.3 mg/ml. Fur-
ther concentration of NEMO resulted in aggregation and precipitation under our current buff-
er conditions. The identity of purified NEMO protein was validated by MS/MS analysis as well
as by IKKβ interaction in vitro and association with appropriate ubiquitin chains (data not
shown). The NEMO purification protocol described here thus may be useful for purification of
non-human NEMO proteins as well as future in vitro studies of NEMO in NF-κB signaling.
Supporting Information
S1 Fig. Protein sequence coverage of human NEMO sequence by MS/MS analysis.Matched
peptide sequences are shown in yellow in the diagram and red in amino acid sequences.
(TIF)
S2 Fig. Determination of the average number of NEMOmolecules in the C5 clone. Nar-
rowed amount range of purified recombinant human NEMO proteins were analyzed with pro-
tein extracts from the indicated number of C5 cells.
(TIF)
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